Bausch Health [BHC] vs Lantheus Holdings [LNTH] Detailed Stock Comparison

Bausch Health Companies Inc.

NYSE
Loading...

Lantheus Holdings Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Bausch Health Companies Inc. wins in 12 metrics, Lantheus Holdings Inc. wins in 8 metrics, with 0 ties. Bausch Health Companies Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Bausch Health Companies Inc. Lantheus Holdings Inc. Better
P/E Ratio (TTM) 13.19 24.30 Bausch Health Companies Inc.
Price-to-Book Ratio 5.58 4.91 Lantheus Holdings Inc.
Debt-to-Equity Ratio 5,591.25 57.19 Lantheus Holdings Inc.
PEG Ratio -0.06 -0.04 Lantheus Holdings Inc.
EV/EBITDA 6.69 14.70 Bausch Health Companies Inc.
Profit Margin (TTM) 1.53% 15.15% Lantheus Holdings Inc.
Operating Margin (TTM) 25.79% 19.07% Bausch Health Companies Inc.
EBITDA Margin (TTM) 25.79% 19.07% Bausch Health Companies Inc.
Return on Equity 436.36% 21.45% Bausch Health Companies Inc.
Return on Assets (TTM) 5.18% 9.28% Lantheus Holdings Inc.
Free Cash Flow (TTM) $993.00M $348.64M Bausch Health Companies Inc.
1-Year Return -15.38% 34.29% Lantheus Holdings Inc.
Price-to-Sales Ratio (TTM) 0.20 3.50 Bausch Health Companies Inc.
Enterprise Value $22.75B $5.62B Bausch Health Companies Inc.
EV/Revenue Ratio 2.22 3.65 Bausch Health Companies Inc.
Gross Profit Margin (TTM) 71.46% 59.21% Bausch Health Companies Inc.
Revenue per Share (TTM) $28 $23 Bausch Health Companies Inc.
Earnings per Share (Diluted) $0.42 $3.41 Lantheus Holdings Inc.
Beta (Stock Volatility) 0.40 -0.13 Lantheus Holdings Inc.
Short % of Float 2.00% 10.95% Bausch Health Companies Inc.

Bausch Health Companies Inc. vs Lantheus Holdings Inc. Stock Performance Analysis

Loading Price Chart...

BHC
LNTH

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bausch Health Companies Inc.-1.38%-2.35%-7.93%-0.80%-27.79%-30.79%
Lantheus Holdings Inc.0.14%4.66%11.46%33.34%57.23%55.60%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bausch Health Companies Inc.-15.38%-31.16%-82.74%-77.04%-89.99%-77.64%
Lantheus Holdings Inc.34.29%18.41%324.53%3,800.00%1,525.51%1,525.51%

Performance & Financial Health Analysis: Bausch Health Companies Inc. vs Lantheus Holdings Inc.

MetricBHCLNTH
Market Information
Market Cap i$2.10B$5.39B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i1,154,689641,334
90 Day Avg. Volume i1,376,966839,568
Last Close$4.99$104.67
52 Week Range$4.93 - $8.69$47.25 - $104.99
% from 52W High-42.58%-0.30%
All-Time High$263.81 (Aug 03, 2015)$126.89 (Jul 15, 2024)
% from All-Time High-98.11%-17.51%
Growth Metrics
Quarterly Revenue Growth0.09%0.04%
Quarterly Earnings GrowthN/A0.04%
Financial Health
Profit Margin (TTM) i0.02%0.15%
Operating Margin (TTM) i0.26%0.19%
Return on Equity (TTM) i4.36%0.21%
Debt to Equity (MRQ) i5,591.2557.19
Cash & Liquidity
Book Value per Share (MRQ)$-1.50$16.87
Cash per Share (MRQ)$3.53$5.56
Operating Cash Flow (TTM) i$1.40B$390.14M
Levered Free Cash Flow (TTM) i$1.09B$265.57M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00N/A

Valuation & Enterprise Metrics Analysis: Bausch Health Companies Inc. vs Lantheus Holdings Inc.

MetricBHC (Apr 26, 2026)LNTH (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i13.1924.30
Forward P/E i1.3713.17
PEG Ratio i-0.06-0.04
Price to Sales (TTM) i0.203.50
Price to Book (MRQ) i5.584.91
Market Capitalization
Market Capitalization i$2.10B$5.39B
Enterprise Value i$22.75B$5.62B
Enterprise Value Metrics
Enterprise to Revenue i2.223.65
Enterprise to EBITDA i6.6914.70
Risk & Other Metrics
Beta i0.40-0.13
Book Value per Share (MRQ) i$-1.50$16.87

Financial Statements Comparison: Bausch Health Companies Inc. vs Lantheus Holdings Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBHC (2025)LNTH (2025)
Revenue/Sales i10.27B1.54B
Cost of Goods Sold i3.01B599.66M
COGS % of Revenue i29.3%38.9%
Gross Profit i7.25B941.95M
Gross Margin i70.7%61.1%
Research & Development i629.00M177.31M
Operating Income (EBIT) i2.19B315.56M
Operating Margin i21.3%20.5%
EBITDA i3.44B409.00M
EBITDA Margin i33.5%26.5%
Pre-Tax Income i367.00M313.79M
Pre-Tax Income % of Revenue i3.6%20.4%
Income Tax i247.00M80.23M
Income Tax % of Revenue i2.4%5.2%
Net Income (Profit) i120.00M233.56M
Profit Margin i1.2%15.2%

Balance Sheet & Liquidity Metrics

MetricBHC (2025)LNTH (2025)
Cash & Equivalents i1.31B359.12M
Total Current Assets i6.16B899.96M
Total Current Assets % of Revenue i60.0%58.4%
Total Current Liabilities i4.18B333.42M
Total Current Liabilities % of Revenue i40.7%21.6%
Long-Term Debt i20.62B618.69M
Long-Term Debt % of Revenue i200.8%40.1%
Total Shareholders Equity i377.00M1.09B
Retained Earnings i-9.67B679.50M
Retained Earnings % of Revenue i-94.2%44.1%
Property, Plant & Equipment i112.00M30.98M

Cash Flow Statement Comparison

MetricBHC (2025)LNTH (2025)
Operating Cash Flow i1.36B398.13M
Operating Cash Flow % of Revenue i13.3%25.8%
Capital Expenditures i-397.00MN/A
Free Cash Flow i993.00M348.64M
FCF Margin i9.7%22.6%
Debt Repayment i-11.19B-1.11M
Common Stock Repurchase iN/A-300.02M

Short Interest & Institutional Ownership Analysis

MetricBHCLNTH
Shares Short i5.99M5.36M
Short Ratio i2.674.60
Short % of Float i2.00%10.95%
Shares Outstanding i370.53M64.59M
Float Shares i258.52M58.18M
% Held by Insiders i30.41%2.04%
% Held by Institutions i65.20%109.34%
% Held by Public i4.39%-11.38%

Dividend Analysis & Yield Comparison: Bausch Health Companies Inc. vs Lantheus Holdings Inc.

MetricBHCLNTH
Last 12-Month Dividend i$0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i$0.00N/A
Ex-Dividend DateN/AN/A